GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice
GV1001, a 16 amino acid peptide derived from the catalytic segment of human telomerase reverse transcriptase, was developed as an anti-cancer vaccine. Subsequently, it was found to exhibit anti-inflammatory and anti-Alzheimer’s disease properties. Periodontitis is a risk factor for a variety of syst...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | International Journal of Molecular Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1422-0067/24/16/12566 |
| _version_ | 1797584465829036032 |
|---|---|
| author | Sharon Y. Kim Yun-Jeong Kim Suyang Kim Mersedeh Momeni Alicia Lee Alexandra Treanor Sangjae Kim Reuben H. Kim No-Hee Park |
| author_facet | Sharon Y. Kim Yun-Jeong Kim Suyang Kim Mersedeh Momeni Alicia Lee Alexandra Treanor Sangjae Kim Reuben H. Kim No-Hee Park |
| author_sort | Sharon Y. Kim |
| collection | DOAJ |
| description | GV1001, a 16 amino acid peptide derived from the catalytic segment of human telomerase reverse transcriptase, was developed as an anti-cancer vaccine. Subsequently, it was found to exhibit anti-inflammatory and anti-Alzheimer’s disease properties. Periodontitis is a risk factor for a variety of systemic diseases, including atherosclerosis, a process in which chronic systemic and vascular inflammation results in the formation of plaques containing lipids, macrophages, foam cells, and tissue debris on the vascular intima. Thus, we investigated the effect of GV1001 on the severity of ligature-induced periodontitis, vascular inflammation, and arterial lipid deposition in mice. GV1001 notably reduced the severity of ligature-induced periodontitis by inhibiting gingival and systemic inflammation, alveolar bone loss, and vascular inflammation in wild-type mice. It also significantly lowered the amount of lipid deposition in the arterial wall in <i>ApoE</i>-deficient mice receiving ligature placement without changing the serum lipid profile. In vitro, we found that GV1001 inhibited the Receptor Activator of NF-κB ligand (RANKL)-induced osteoclast formation and tumor necrosis factor-α (TNF-α)-induced phenotypic changes in endothelial cells. In conclusion, our study suggests that GV1001 prevents the exacerbation of periodontitis and atherosclerosis associated with periodontitis partly by inhibiting local, systemic, and vascular inflammation and phenotypic changes of vascular endothelial cells. |
| first_indexed | 2024-03-10T23:53:07Z |
| format | Article |
| id | doaj.art-22bae3ee91a741e993487eec6cda8924 |
| institution | Directory Open Access Journal |
| issn | 1661-6596 1422-0067 |
| language | English |
| last_indexed | 2024-03-10T23:53:07Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Molecular Sciences |
| spelling | doaj.art-22bae3ee91a741e993487eec6cda89242023-11-19T01:25:13ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-08-0124161256610.3390/ijms241612566GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in MiceSharon Y. Kim0Yun-Jeong Kim1Suyang Kim2Mersedeh Momeni3Alicia Lee4Alexandra Treanor5Sangjae Kim6Reuben H. Kim7No-Hee Park8The Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USADepartment of Periodontology, Seoul National University Gwanak Dental Hospital, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 08826, Republic of KoreaThe Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USAThe Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USAThe Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USAThe Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USATeloid Inc., 920 Westholme Avenue, Los Angeles, CA 90024, USAThe Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USAThe Shapiro Family Laboratory of Viral Oncology and Aging Research, UCLA School of Dentistry, 714 Tiverton Ave, Los Angeles, CA 90095, USAGV1001, a 16 amino acid peptide derived from the catalytic segment of human telomerase reverse transcriptase, was developed as an anti-cancer vaccine. Subsequently, it was found to exhibit anti-inflammatory and anti-Alzheimer’s disease properties. Periodontitis is a risk factor for a variety of systemic diseases, including atherosclerosis, a process in which chronic systemic and vascular inflammation results in the formation of plaques containing lipids, macrophages, foam cells, and tissue debris on the vascular intima. Thus, we investigated the effect of GV1001 on the severity of ligature-induced periodontitis, vascular inflammation, and arterial lipid deposition in mice. GV1001 notably reduced the severity of ligature-induced periodontitis by inhibiting gingival and systemic inflammation, alveolar bone loss, and vascular inflammation in wild-type mice. It also significantly lowered the amount of lipid deposition in the arterial wall in <i>ApoE</i>-deficient mice receiving ligature placement without changing the serum lipid profile. In vitro, we found that GV1001 inhibited the Receptor Activator of NF-κB ligand (RANKL)-induced osteoclast formation and tumor necrosis factor-α (TNF-α)-induced phenotypic changes in endothelial cells. In conclusion, our study suggests that GV1001 prevents the exacerbation of periodontitis and atherosclerosis associated with periodontitis partly by inhibiting local, systemic, and vascular inflammation and phenotypic changes of vascular endothelial cells.https://www.mdpi.com/1422-0067/24/16/12566GV1001periodontitissystemic and vascular inflammationatherosclerosis |
| spellingShingle | Sharon Y. Kim Yun-Jeong Kim Suyang Kim Mersedeh Momeni Alicia Lee Alexandra Treanor Sangjae Kim Reuben H. Kim No-Hee Park GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice International Journal of Molecular Sciences GV1001 periodontitis systemic and vascular inflammation atherosclerosis |
| title | GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice |
| title_full | GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice |
| title_fullStr | GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice |
| title_full_unstemmed | GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice |
| title_short | GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice |
| title_sort | gv1001 inhibits the severity of the ligature induced periodontitis and the vascular lipid deposition associated with the periodontitis in mice |
| topic | GV1001 periodontitis systemic and vascular inflammation atherosclerosis |
| url | https://www.mdpi.com/1422-0067/24/16/12566 |
| work_keys_str_mv | AT sharonykim gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT yunjeongkim gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT suyangkim gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT mersedehmomeni gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT alicialee gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT alexandratreanor gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT sangjaekim gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT reubenhkim gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice AT noheepark gv1001inhibitstheseverityoftheligatureinducedperiodontitisandthevascularlipiddepositionassociatedwiththeperiodontitisinmice |